ReNeuron Group Share Price (RENE)

1.40 -0.15 (-9.68%) delayed: 11:22PM GMT
Bid price 1.35 Open price 1.57
Ask price 1.45 Prev close 1.40
High price 1.57 Spread 6.90%
Low price 1.38 Volume 27,409,415

Register now for FREE live ReNeuron Group share prices, ReNeuron Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get ReNeuron Group Level 2 Data, indepth research tools and investor commentary for ReNeuron Group (RENE) and other London Stock Exchange equities.

ReNeuron Group Share Price Chart

Advanced Charts >>

Register now for FREE ReNeuron Group share price charts

ReNeuron Group Share Price Information

Name ReNeuron Group Epic RENE
Sector Pharmaceuticals & Biotechnology ISIN GB00B0DZML60
Activites ReNeuron Group plc is a leading, clinical-stage cell therapy development company. Based in the UK, its primary objective is the development of novel cell-based therapies targeting areas of significant unmet or poorly met medical need. ReNeuron has used its unique stem cell technologies to develop cell-based therapies for significant disease conditions where the cells can be readily administered off-the-shelf to any eligible patient without the need for additional immunosuppressive drug treatments. The Company has therapeutic candidates in clinical development for disability as a result of stroke, for critical limb ischaemia and for the blindness-causing disease, retinitis pigmentosa. ReNeuron is also advancing its proprietary exosome technology platform as a potential new nanomedicine targeting cancer and as a potential delivery system for drugs that would otherwise be unable to reach their site of action. Index n/a

ReNeuron Group Key Numbers

Latest Share Price (p) 1.40 Net Gearing (%) -38.09
Market Capitalisation (£m) 49.05 Gross Gearing (%) 9.69
Shares in issue (m) 3,164.62 Debt Ratio 0.00
P/E Ratio -3.10 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.11
Dividend Yield (%) 0.00 Price to book value 0.92
Dividend cover (x) 0.00 ROCE (%) -34.18
Earning per share (p) -0.50 EPS Growth (%) -25.00
52 week high / low 2.65 / 1.55 DPS Growth (%) n/a

ReNeuron Group Director Deals

Dec.Date Type Director Pos No. of Shares
07/02/2017 BUY Michael Hunt ED 250,000
17/02/2016 EXR Michael Hunt ED 5,361,673
17/02/2016 SEXR Michael Hunt ED 5,111,673
03/02/2016 BUY John Berriman CH 318,476
30/01/2015 BUY Olav Hellebo CEO 322,778

More ReNeuron Group Director Deals >>

ReNeuron Group Company News

07:00 11/01/2018

Further re Share Capital Reorganisation

RNS Number : 5473B ReNeuron Group plc 11 January 2018     11 January 2018 AIM: RENE   ReNeuron Group plc ("ReNeuron" or the "Company")   Share Capital Reorganisation - Allotment of Ordinary Shares & Irrevocable Undertaking...

08:08 05/01/2018

ReNeuron Group plans share reduction

ReNeuron Group has launched a capital reorganisation what will reduce the number of shares in the company by a factor of 100, whilst increasing the trading price of each share. The company said the move would create a capital structure more conducive to attracting new institutional investors, in...

07:00 05/01/2018

Proposed Share Capital Reorganisation

RNS Number : 0371B ReNeuron Group plc 05 January 2018     5 January 2018 AIM: RENE   ReNeuron Group plc ("ReNeuron" or the "Company")   Proposed Share Capital Reorganisation and Notice of General Meeting     Share consolidation...

More ReNeuron Group Company News >>

Register now for FREE ReNeuron Group company news

ReNeuron Group Share Price Discussions

7 months ago

RENEURON- stem cell technology (RENE)

Think this one could have the potetial to be really big... Check out the company info and post any thoughts you have... has massive potential

more than 1 year ago

BAD NEWS (RENE)

INVESTORS FUNDS WILL BE SEIZED

Register now for FREE ReNeuron Group share price discussions